Under the agreement, Philip Morris will use Medicago’s technologies and VLPs for developing, manufacturing Medicago’s pandemic and seasonal influenza vaccines in china. The terms of Philip Morris’ deal
AEZS-130 patent came into effect from 19 September 2012 and will be valid till 19 February 2027. Aeterna Zentaris president and CEO Juergen Engel said the patent in
Pervenio Lung RS is also expected to meet prognostic information needed to guide preventative treatment and improve disease management. The test consists of a quantitative PCR (polymerase chain
The FDA has not granted orphan drug exclusivity to Gralise, even though the product was approved for orphan drug designation in November 2010 for the management of PHN
The patent will extend coverage period by at least until 2031, which is nine years longer than the granted patent coverage earlier to the company. The patent applications
The milestone was triggered as a result of the transition of an oncology programme into pre-clinical profiling. Evotec chief operating officer Dr Mario Polywka said under the alliance
Under the terms of the agreement, Atreca will apply the technology to particular infectious diseases and share the results with the foundation for use in the discovery and
Raspberry Keytone is designed for increasing the levels of protein hormone, adiponectin, which modulates glucose regulation and fatty acidcatabolism processes. Past research into adiponectin has shown that adiponectin
The randomised, double-blind trial will compare progression-free survival in 329 post-ASCT patients receiving Adcetris to those receiving placebo. Patients receive Adcetris every three weeks for up to one
The study will enroll over 300 patients at 24 clinical sites in four countries worldwide to access the efficacy and to evaluate two different dosage regimens of the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.